SecBot SecBot
3 ·Filed Oct 5, 2026

OSTX

OS Therapies Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed20d 16h ago SEC0001213900-26-106857
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

No trading signal from this filing. Monitor future Form 4 filings for any open-market purchases or sales by the CFO for insider conviction signals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
OSTX ▼ -2.68% at T+5d
NEUTRAL call -2.68% · α vs SPY -2.55% · entry $1.49 → $1.45
Next anchor: T+20d in 7d
Latest observation: T+13 -11.89% FF3 residual α
Entry = T+0 close
Oct 5, 2026
via day close
T+1d
+4.03%
call +4.03% · α +4.27%
$1.55
settled 20d ago
T+5d
-2.68%
call -2.68% · α -2.55%
$1.45
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Francis Knuettel II, the newly appointed Chief Financial Officer of OS Therapies Inc, filed a Form 3 initial statement of beneficial ownership, disclosing 20,000 shares of common stock held indirectly through the Lara Knuettel Revocable Trust. This is a routine insider filing required upon becoming an officer and does not convey any new trading signal.

Key Facts

  • Francis Knuettel II appointed as Chief Financial Officer of OS Therapies Inc.
  • Form 3 filed on 2026-10-05, reporting period 2026-09-29.
  • Beneficial ownership: 20,000 shares of common stock held indirectly via the Lara Knuettel Revocable Trust.
  • Shares held indirectly through a trust; reporting person disclaims beneficial ownership except for pecuniary interest.
  • Power of Attorney granted to Paul A. Romness and Christopher P. Acevedo for Section 13/16 filings.

Financial Impact

No financial impact — this is a routine initial ownership disclosure with no transaction.

Risk Factors

  • No material risks identified from this routine filing.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001213900-26-106857
Document: 0001213900-26-106857-index-headers.html0001213900-26-106857
Document: 0001213900-26-106857-index.html0001213900-26-106857
Document: 0001213900-26-106857.txt0001213900-26-106857
4 reports for OSTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OSTX — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
8-K
BULLISH ★ 6/10
$1.27 $1.26▼ −0.79%▼ −1.12%$1.25 (−1.57%)
Oct 5, 2026
20d ago
3
NEUTRAL ★ 2/10
$1.49 $1.55▲ +4.03%▲ +4.27%$1.25 (−16.11%)
Oct 5, 2026
20d ago
8-K
NEUTRAL ★ 5/10
$1.49 $1.55▲ +4.03%▲ +4.27%$1.25 (−16.11%)
Jul 29, 2026
12w ago
8-K
BULLISH ★ 6/10
$1.56 $1.52▼ −2.56%▼ −3.27%$1.25 (−19.87%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 5, 2026